EDITOR’S CHOICE
Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn’s disease, by Nikolic et al
First published: 26 January 2021
No abstract is available for this article.
REFERENCES
- 1Nikolic M, Stift A, Reinisch W, Vogelsang H, Matic A, Muller C, et al. Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease. Colorectal Dis. 2020; doi: https://doi.org/10.1111/codi.15324.
- 2Garcia-Arranz M, Herreros MD, Gonzalez-Gomez C, de la Quintana P, Guadalajara H, Georgiev-Hristov T, et al. Treatment of Crohn's-related rectovaginal fistula with allogeneic expanded-adipose derived stem cells: a phase I-IIa clinical trial. Stem Cells Transl Med. 2016; 5: 1441–6.
- 3Panes J, Garcia-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's Disease. Gastroenterology. 2018; 154: 1334–42.e4.
